Hurlow Wealth Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.08M Buy
3,352
+6
+0.2% +$6.08K 0.73% 26
2025
Q4
$3.6M Sell
3,346
-8
-0.2% -$7.65K 0.88% 24
2025
Q3
$2.56M Sell
3,354
-2,285
-41% -$1.7M 0.66% 25
2025
Q2
$4.4M Sell
5,639
-499
-8% -$388K 1.24% 21
2025
Q1
$5.07M Buy
6,138
+40
+0.7% +$33.3K 1.58% 19
2024
Q4
$4.71M Sell
6,098
-144
-2% -$119K 1.47% 20
2024
Q3
$5.53M Buy
6,242
+107
+2% +$96.2K 1.72% 19
2024
Q2
$5.55M Buy
6,135
+200
+3% +$160K 1.91% 17
2024
Q1
$4.62M Buy
5,935
+10
+0.2% +$7.12K 1.63% 18
2023
Q4
$3.45M Buy
5,925
+159
+3% +$92.8K 1.31% 19
2023
Q3
$3.1M Sell
5,766
-20
-0.3% -$10.3K 1.35% 19
2023
Q2
$2.71M Buy
5,786
+8
+0.1% +$3.35K 1.16% 20
2023
Q1
$1.98M Sell
5,778
-7
-0.1% -$2.36K 0.92% 23
2022
Q4
$2.12M Sell
5,785
-883
-13% -$313K 1.1% 22
2022
Q3
$2.16M Hold
6,668
1.26% 21
2022
Q2
$2.16M Hold
6,668
1.25% 19
2022
Q1
$1.91M Sell
6,668
-313
-4% -$80.6K 1.17% 18
2021
Q4
$1.45M Buy
6,981
+300
+4% +$76.1K 1.14% 18
2021
Q3
$1.54M Hold
6,681
0.92% 22
2021
Q2
$1.53M Sell
6,681
-300
-4% -$60.3K 1.01% 20
2021
Q1
$1.3M Sell
6,981
-40
-0.6% -$7.82K 0.94% 21
2020
Q4
$1.19M Hold
7,021
0.93% 20
2020
Q3
$1.04M Sell
7,021
-120
-2% -$18.6K 0.95% 20
2020
Q2
$1.16M Buy
7,141
+20
+0.3% +$3.07K 1.12% 18
2020
Q1
$1.08M Sell
7,121
-40
-0.6% -$5.5K 1.15% 19
2019
Q4
$1.01M Sell
7,161
-5
-0.1% -$580 0.99% 21
2019
Q3
$773K Hold
7,166
0.82% 24
2019
Q2
$784K Sell
7,166
-16
-0.2% -$1.88K 0.82% 26
2019
Q1
$841K Hold
7,182
0.9% 23
2018
Q4
$826K Buy
+7,182
New +$802K 1% 22

Other funds holding LLY

Hurlow Wealth Management Group's LLY Position: Q1 2026 in Review

Hurlow Wealth Management Group increased its Eli Lilly (LLY) stake by 0.18% in Q1 2026, buying an estimated $6.08K and bringing the position to 3,352 shares worth $3.08M. The position accounts for 0.73% of the portfolio, ranked #26.

Hurlow Wealth Management Group first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $5.55M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Hurlow Wealth Management Group held 3,352 shares of Eli Lilly worth $3.08M as of Q1 2026.
  • Hurlow Wealth Management Group bought 6 Eli Lilly shares in Q1 2026, an estimated $6.08K.
  • Eli Lilly made up 0.73% of Hurlow Wealth Management Group's portfolio in Q1 2026, its #26 holding.
  • Hurlow Wealth Management Group first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Hurlow Wealth Management Group's Eli Lilly position peaked at $5.55M in Q2 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Hurlow Wealth Management Group's 13F filing for Q1 2026, filed 22 Apr 2026.